Figure 1 (IMAGE)

Nagoya University

Figure 1

Caption

A formamide modification (yellow) to a therapeutic agent siRNA (blue) prevents siRNA to bind to non-target mRNA, which allows for treatment with less side effects.

Credit

Reiko Matsushita

Usage Restrictions

Credit must be given where image is used

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.